Statins

	Novel HDL-Booster Impressive in Early Study
	ORLANDO -- Evacetrapib, an investigational drug that boosts HDL while lowering LDL, appears to be safe as monotherapy or as an add-on to statin therapy, with no evidence of the off-target toxicity that sunk another CETP-inhibitor, torcetrapib. Full story Lipitor, Crestor Both Turn Back Plaque ORLANDO -- Aggressive treatment with potent statins appears to reverse the build-up of plaque in arteries, and the benefit was the same whether the statin used was rosuvastatin (Crestor) or atorvastatin (Lipitor), researchers said here. Full story